| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |